Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
4(21%)
Results Posted
100%(3 trials)
Terminated
2(11%)

Phase Distribution

Ph phase_2
12
63%
Ph phase_1
3
16%
Ph phase_3
4
21%

Phase Distribution

3

Early Stage

12

Mid Stage

4

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
3(15.8%)
Phase 2Efficacy & side effects
12(63.2%)
Phase 3Large-scale testing
4(21.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

4

trials recruiting

Total Trials

19

all time

Status Distribution
Active(7)
Completed(3)
Terminated(3)
Other(6)

Detailed Status

unknown6
Not yet recruiting3
Completed3
Recruiting2
Terminated2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
19
Active
4
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (15.8%)
Phase 212 (63.2%)
Phase 34 (21.1%)

Trials by Status

not_yet_recruiting316%
recruiting211%
completed316%
unknown632%
withdrawn15%
terminated211%
active_not_recruiting211%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT07524257Phase 3

Phase 3 Study of Nogapendekin Alfa Inbakicept Plus Standard of Care vs Standard of Care in First-Line Advanced or Metastatic NSCLC

Not Yet Recruiting
NCT07538258Phase 2

Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer

Not Yet Recruiting
NCT07005336Phase 2

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

Active Not Recruiting
NCT04162015Phase 1

A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

Active Not Recruiting
NCT06839105Phase 1

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

Recruiting
NCT06829459Phase 3

A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs

Recruiting
NCT04868708Phase 2

A Study of AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

Completed
NCT06299371Phase 2

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Not Yet Recruiting
NCT05948462Phase 2

Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib

Withdrawn
NCT05151549Phase 2

A Study of Carilizumab Combined With Concurrent Chemoradiotherapy

Unknown
NCT04974827Phase 2

A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer

Unknown
NCT03912415Phase 3

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA)

Unknown
NCT03912389Phase 3

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC

Unknown
NCT01859741Phase 1

A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy

Terminated
NCT03912402Phase 2

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Unknown
NCT02397928Phase 2

Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)

Completed
NCT01218048Phase 2

ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma

Completed
NCT00977561Phase 2

A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

Terminated
NCT01192243Phase 2

Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients

Unknown

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19